Altria Group, Inc. (MO)
FDA approves sales of Juul's e-cigarettes in the US
The US Food and Drug Administration (FDA) has approved the sale of Juul's e-cigarette device and its refill cartridges in tobacco and menthol flavors. The Washington, DC-based private firm said on Thursday the FDA has determined its products are "appropriate for the protection of public health,” meeting the statutory requirement for introducing new tobacco products onto the US market.
Are Consumer Staples Stocks Lagging Altria Group (MO) This Year?
Here is how Altria (MO) and Carlsberg AS (CABGY) have performed compared to their sector so far this year.
People Don't Want To Invest In This Company, But It Has A Great Stock
Altria (NYSE: MO) makes some of the world's most dangerous products.
Behind Altria's Profit Resilience: The Power of Pricing Strategy
MO leans on pricing power to lift profits, offsetting cigarette volume drops and regulatory headwinds.
Will Altria (MO) Beat Estimates Again in Its Next Earnings Report?
Altria (MO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Altria (MO) Stock Dips While Market Gains: Key Facts
Altria (MO) closed at $57.75 in the latest trading session, marking a -3.01% move from the prior day.
Why Altria (MO) is a Top Growth Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here is What to Know Beyond Why Altria Group, Inc. (MO) is a Trending Stock
Zacks.com users have recently been watching Altria (MO) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Altria Group Gains 21% in 6 Months: How to Play the Stock?
MO is gaining ground with strong Marlboro pricing, smoke-free growth, and solid value, appealing to income-focused investors.
2 High-Yield Dividend Stocks I Won't Ever Sell
Key Points in This Article: Dividend investing provides steady income and potential capital growth, with high-yield stocks offering reliable cash flow for reinvestment or personal use.
Altria's Dividend Is Aging Like Fine Wine
Altria Group, Inc.'s consistent dividend growth continues, with a 56th consecutive increase expected soon, highlighting its shareholder commitment despite industry headwinds. Key metrics—free cash flow, payout ratio, and dividend per share—have all improved since 2016, even as the core business faces decline. I forecast a 4% dividend increase, pushing the MO stock yield to 7%, supported by strong cash flow.
I Was Wrong About Altria, There Is Upside After All (Rating Upgrade)
I underestimated Altria's pricing power and margin expansion, which have effectively offset declining cigarette volumes and supported strong EPS growth. Altria's transition to smoke-free products is slower than peers, but ON! nicotine pouches are gaining traction and boosting profitability despite NJOY setbacks. Shares trade at a 20% discount to historical averages, offering a 6.8% yield and potential 12-13% annual total returns for income-focused investors.
